A CYP3A4 Phenotype-Based Dosing Algorithm for Individualized Treatment of Irinotecan

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-09-1526
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Individualized Treatment for a Rectourethral Fistula: Rare Complications

Annals of Coloproctology
Gastroenterology
2014English

Individualized Treatment for a Case of Recurrent Ovarian Ependymoma

OncoTargets and Therapy
OncologyPharmacology
2018English

Flat-Fixed Dosing of Irinotecan: Influence on Pharmacokinetic and Pharmacodynamic Variability

Clinical Cancer Research
Cancer ResearchOncology
2004English

Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2015English

Treatment Outcome of Irinotecan Monotherapy

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2003English

Individualized Treatment Approaches for Langerhans Cell Histiocytosis

British Journal of Dermatology
DermatologyMedicine
2018English

Individualized Dosing of Aminoglycosides in Neonates: Mission Accomplished or Work in Progress?

European Journal of Clinical Pharmacology
MedicinePharmacology
2009English

Economic Evaluation of a Pharmacogenetic Dosing Algorithm for Coumarin Anticoagulants in the Netherlands

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2015English

A Cost Utility Analysis of CYP2D6 Pharmacogenetic Guided Dosing Versus Standard Dosing of Risperidone for Treatment of Schizophrenia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy